In-Hospital Mortality and Treatment in Patients With Acute Coronary Syndrome With and Without Standard Modifiable
Wei Gong1,2,3, Yan Yan1,2,3, Jing Liu4
1Center for Coronary Artery Disease, Division of Cardiology, Beijing Anzhen Hospital Capital Medical University Beijing China.
Patients with acute coronary syndrome (ACS) lacking standard modifiable cardiovascular risk factors (SMuRFs) face higher mortality. Guideline-directed medical therapy showed reduced effectiveness in these SMuRF-less individuals, necessitating further research for optimal treatment strategies.
Area of Science:
- Cardiology
- Clinical Research
- Public Health
Background:
- Acute coronary syndrome (ACS) patients without standard modifiable cardiovascular risk factors (SMuRFs) are understudied.
- Limited data exists on their characteristics, care quality, and outcomes.
Purpose of the Study:
- To systematically analyze ACS patients without SMuRFs.
- To evaluate the effectiveness of guideline-directed medical therapy (GDMT) in this population.
Main Methods:
- Analysis of 89,462 patients from the CCC-ACS project (2014-2019).
- Categorization of patients based on the presence or absence of SMuRFs (hypertension, smoking, dyslipidemia, diabetes).
- Assessment of in-hospital all-cause mortality and GDMT receipt.
Main Results:
- 11.0% of ACS patients were SMuRF-less.
- SMuRF-less patients had higher in-hospital mortality (adjusted HR, 1.35).
- GDMT was not associated with lower mortality in SMuRF-less patients (adjusted HR, 0.98), unlike in patients with SMuRFs (adjusted HR, 0.80).
Conclusions:
- SMuRF-less ACS patients have an increased risk of in-hospital mortality.
- GDMT is less effective in SMuRF-less ACS patients compared to those with SMuRFs.
- Further studies are required to determine optimal therapies for SMuRF-less ACS patients.
More Related Videos
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome V: Nursing Management
